Since its creation in 1962, Pierre Fabre combines loyalty to its regional roots and global development.
Present commercially in 130 countries, it is run from Castres and Lavaur in the Tarn, conducts its research primarily in the Occitanie region and provides more than 90% of its industrial production in France.
Production in France
Pierre Fabre carries out over 90% of its industrial production in France in 8 factories, 5 of which are situated in the Occitanie region (Tarn, Hérault, Gers, Lot), 1 in the Pyrénées-Atlantiques department and 2 in the Loiret department. In 2016, these factories produced 534 million units, equating to 17 products per second! They employ over 2,400 people: 50% of these are in the Occitanie region, with further employees in 2 logistical distribution centers operated by the group in Haute-Garonne and Corrèze.
Innovation in France
Pierre Fabre has 7 research and development centers in France: 6 in the Occitanie region (in Toulouse, Castres, Gaillac and Avène) and 1 in the department of Haute-Savoie (in Saint-Julien-en-Genevois). The group is, in particular, present at the Toulouse Oncopole, Europe's first campus to be entirely devoted to combating cancer. The Oncopole stands on the site where the AZF disaster occurred in 2001; Pierre Fabre played a key role in regenerating the site, as the first pharmaceutical laboratory to install its research teams there. The group has over 900 employees in its R&D department, and devoted 195 million euros to it in 2016 (8.5% of its net sales).
Investment in France
Over the last five years, the group has invested almost 400 million euros in Occitanie. Flagship projects include the extension of the ultra-modern dermo-cosmetics plants in Soual (Tarn) and Avène (in the Haut-Languedoc Natural Park), and the new head office of the Pierre Fabre Consumer Health Care division. This division opened in Castres last July, confirming the group's unwavering attachment to the city where it was born and grew.